Shire bids to buy newly spun-out Baxalta for $30B
August 04, 2015 at 07:54 AM EDT
Shire Pharmaceuticals, which is based in Ireland but has its CEO and most executives in Lexington, has bid to buy the newly spun-out pharmaceutical company from Baxter International called Baxalta for more than $45 a share, a 36 percent premium to its shares price yesterday...
